Current Illinois CancerCare Clinical Trals

Renal Cell/Kidney Cancer


A032201

Short TeRm Intensified Pembrolizumab (KEytruda) and Tivozanib for High-Risk Renal Cell Carcinoma - STRIKE


Search Again